3 Things to Watch With Nektar Therapeutics

Published November 23, 2012

3 Things to Watch With Nektar Therapeutics

Filed under: drug treatment news articles

The FDA recently awarded a fast-track designation to Nektar's phase 3 drug etirinotecan pegol, a treatment for metastatic breast cancer. This status is given to drugs that treat serious medical conditions fulfilling an unmet need, and it could lead to …
Read more on Motley Fool

African Healthcare Desperately Needs a Shot in the Arm

Filed under: drug treatment news articles

Inexpensive generic drugs for the treatment of HIV, supplied by a few pharmaceutical firms from the likes of India, have made a big difference in Africa. … Think Africa Press welcomes inquiries regarding the republication of its articles. If you …
Read more on Think Africa Press